Inhibition of fatty acid synthase with FT-4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non-alcoholic fatty liver disease: Results from two early-phase randomized trials
Author: C Beysen, P Schroeder, E Wu, J Brevard, et al.
Year Published: 2021
Media Outlet: Diabetes, Obesity, and Metabolism
Open Access? No
Matrix:
Biological Themes:
Product(s):
![Metabolon PUBLICATION Metabolon PUBLICATION](https://www.metabolon.com/wp-content/uploads/2022/11/Metabolon-PUBLICATION@2x.png)
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.
Contact Us
Talk with an expert
Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.
Corporate Headquarters
617 Davis Drive, Suite 100
Morrisville, NC 27560
+1 (919) 572-1721